You may have heard by now about the rush for life sciences space in the wake of last year’s COVID-19 outbreak, which could still continue even after the virus is under control. New Jersey, of course, should stand to benefit with a deep pool of intellectual talent that rose to the occasion in the nation’s fight against the pandemic.
Prism Capital Partners has relocated its headquarters to 310 Kingsland Street at ON3, the commercial real estate owner/operator’s 116-acre flagship redevelopment spanning Nutley and Clifton. Prism’s move from 200 Metro Boulevard makes way for Eisai Inc.
Prism Capital Partners’ blockbuster lease with pharmaceutical company Eisai Inc. at ON3 marked NJ’s largest 2020 office lease.
Eugene Diaz and Edwin Cohen, principal partners of Prism Capital Partners, the Nutley-based developer of the ON3 campus, have been named among the ROI-NJ “Influencers: Power List 2021 — Real Estate.”
David Perlin, Ph.D., the chief scientific officer and senior VP of the Center for Discovery and Innovation, was named to the ROI Influencers: Power List 2021 – Health Care. Perlin was cited for leading the CDI team that developed the first privately-created viral diagnostic for COVID-19 amid the first wave of the pandemic.